Prevention of cancers of the breast, endometrium and ovary (Q35868030)

10 August 2017

1 reference

title

Prevention of cancers of the breast, endometrium and ovary (English)

1 reference

10 August 2017

2

Celeste Leigh Pearce

1 reference

10 August 2017

3

Anna H Wu

1 reference

10 August 2017

Malcolm C Pike

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

23

1 reference

10 August 2017

issue

38

1 reference

10 August 2017

page(s)

6379-6391

1 reference

Is the risk of cancer of the corpus uteri reduced by a recent pregnancy? A prospective study of 765,756 Norwegian women

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Intratumoral levels of estrogens in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Heritability of mammographic density, a risk factor for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Somatic stem cells and the kinetics of mutagenesis and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

"Incessant ovulation" and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Variation in mammographic breast density by race

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Postmenopausal hormone therapy and change in mammographic density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

The epidemiology of endometrial cancer in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Secular trends in the distributions of the breast cancer risk factors--menarche, first birth, menopause, and weight--in Hiroshima and Nagasaki, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Pregnancy, breast-cancer risk, and maternal-fetal genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Sex hormones in women in rural China and in Britain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Childbearing at older age and endometrial cancer risk (Sweden)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Tamoxifen prevention of breast cancer: an instance of the fingerpost

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Body mass index in relation to ovarian cancer: A multi-centre nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Estrogen-progestin replacement therapy and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

LHRH agonists and the prevention of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Hormone replacement therapy and risk of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Body size and ovarian cancer: case-control study and systematic review (Australia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Parity, contraception, infertility, and the risk of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Low-dose oral contraceptives: protective effect on ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

The action of chorionic gonadotrophin in the obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Menstrual and reproductive factors in relation to ovarian cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Reproductive Factors and Epithelial Ovarian Cancer Risk by Histologic Type:A Multiethnic Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Effect of reproductive hormones on ovarian epithelial tumors: I. Effect on cell cycle activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

The reduction in risk of ovarian cancer associated with oral-contraceptive use

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy. The Scandinavian LongCycle Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Association of obesity and ovarian cancer in a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Breast cancer and the oestrogen window hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Epidemiology and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Body mass index at age 18 years and during adult life and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Endometrial disease after treatment with oestrogens and progestogens in the climacteric

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Menstruation span--a time-limited risk factor for endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207899

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207899

1 reference

10 August 2017

1 reference